<qa>  What is the primary outcome of PACE protocol or MI?We will deliver the PACE protocol or MI for 6 months, using both face-to-face visits and telephone contact. Our primary outcome is walking distance as measured by the widely used and well-validated 6-minute walk test at the end of active intervention 6 months. Secondary outcomes are walking distance as measured beyond the active phase of intervention 12 months, use of home-based walking as measured by accelerometry, and lower limb blood flow as measured by the ankle brachial index - ABI. Our comparison group will receive the same print material as the two interventions as well as contact every three months to update any changes in contact information and to assess their health status. We will randomize 204 participants to one of three arms: Control or Treatment One Tx1; PACE or Treatment Two Tx2; or MI, also referred to as Treatment Three Tx3. In addition, we will determine the efficacy of PACE Tx2 to increase walking distance in AAs with PAD, compared to Control Tx1. 